Kalshi launches drug trial and regulatory decision contracts
By The Weekly Edge desk ·
Summary
BNLData reported that Kalshi introduced contracts related to medicine trials and regulatory decisions. The US offering includes contracts on drug approvals involving Sanofi and Gilead Sciences.
Why it matters
The products extend Kalshi’s event contracts into biotechnology and medicine regulation.